These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15361263)

  • 81. Inflammation in depression: is adiposity a cause?
    Shelton RC; Miller AH
    Dialogues Clin Neurosci; 2011; 13(1):41-53. PubMed ID: 21485745
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Incomplete remission in depression: role of psychiatric and somatic comorbidity.
    Otte C
    Dialogues Clin Neurosci; 2008; 10(4):453-60. PubMed ID: 19170402
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.
    Papakostas GI; Fava M
    Dialogues Clin Neurosci; 2008; 10(4):439-51. PubMed ID: 19170401
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Obesity and weight gain in relation to depression: findings from the Stirling County Study.
    Murphy JM; Horton NJ; Burke JD; Monson RR; Laird NM; Lesage A; Sobol AM
    Int J Obes (Lond); 2009 Mar; 33(3):335-41. PubMed ID: 19139752
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.
    Lotrich FE; Pollock BG; Kirshner M; Ferrell RF; Reynolds Iii CF
    J Psychiatry Neurosci; 2008 Mar; 33(2):123-30. PubMed ID: 18330458
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Olfactory bulbectomy increases food intake and hypothalamic neuropeptide Y in obesity-prone but not obesity-resistant rats.
    Primeaux SD; Barnes MJ; Bray GA
    Behav Brain Res; 2007 Jun; 180(2):190-6. PubMed ID: 17420059
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Depressive disorder subtypes, depressive symptom clusters, and risk of obesity and diabetes: A systematic review.
    Shell AL; Crawford CA; Cyders MA; Hirsh AT; Stewart JC
    J Affect Disord; 2024 May; 353():70-89. PubMed ID: 38432462
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
    Papakostas GI; Petersen T; Denninger JW; Tossani E; Pava JA; Alpert JE; Nierenberg AA; Fava M
    J Clin Psychopharmacol; 2004 Oct; 24(5):507-11. PubMed ID: 15349006
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
    Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.
    Cassano P; Soares CN; Cohen LS; Lyster AK; Fava M
    Arch Womens Ment Health; 2004 Jul; 7(3):167-71. PubMed ID: 15241662
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
    Papakostas GI; Petersen T; Denninger JW; Montoya HD; Nierenberg AA; Alpert JE; Fava M
    Ann Clin Psychiatry; 2003; 15(3-4):187-92. PubMed ID: 14971864
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Obesity among outpatients with major depressive disorder.
    Papakostas GI; Petersen T; Iosifescu DV; Burns AM; Nierenberg AA; Alpert JE; Rosenbaum JF; Fava M
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):59-63. PubMed ID: 15361263
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Weight changes in adults with major depressive disorder: A systematic review and meta-analysis of prospective studies.
    Treviño-Alvarez AM; Sánchez-Ruiz JA; Barrera FJ; Rodríguez-Bautista M; Romo-Nava F; McElroy SL; Cuéllar-Barboza AB
    J Affect Disord; 2023 Jul; 332():1-8. PubMed ID: 36963517
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.